Cormorant Asset Management, LP - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 92 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$2,593,000
-28.1%
850,0000.0%0.41%
-13.6%
Q2 2015$3,604,000
+9.8%
850,0000.0%0.48%
-5.5%
Q1 2015$3,281,000
-51.2%
850,000
-15.0%
0.51%
-51.2%
Q4 2014$6,730,000
+22.6%
1,000,0000.0%1.04%
-8.1%
Q3 2014$5,490,000
-23.5%
1,000,000
+42.9%
1.13%
-40.6%
Q2 2014$7,175,000
-20.3%
700,000
-6.7%
1.90%
-8.2%
Q1 2014$9,008,000
+6.2%
750,0000.0%2.07%
-15.9%
Q4 2013$8,483,000750,0002.46%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
LINCOLN CAPITAL CORP 34,250$116,0000.11%
Kovack Advisors, Inc. 24,393$82,0000.02%
Cedar Wealth Management, LLC 12,000$41,0000.02%
Ausdal Financial Partners, Inc. 19,590$66,0000.02%
HRT FINANCIAL LP 15,990$53,0000.02%
Granite Investment Partners, LLC 53,853$182,0000.01%
Joel Isaacson & Co., LLC 20,000$68,0000.01%
GSA CAPITAL PARTNERS LLP 53,658$181,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 246,150$831,0000.01%
Dynamic Technology Lab Private Ltd 15,108$51,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders